Method for maintaining a continuously-saturated level of ascorbi

Details Method for maintaining a continuously-saturated level of ascorbi Method for maintaining a continuously-saturated level of ascorbi

1994-10-03

1996-09-24

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

424464, A61K 920

Patent

active

055588700

ABSTRACT:
A method of administration of vitamin C to ensure that a continuously-saturated level is produced in the body of a taker. A dose of about 500 mg taken approximately every 12 hours produces a continuously-detectable level of vitamin C in the urine of an average healthy person, which corresponds to a sufficiently high pool of ascorbic acid in the body to provide anti-oxidant protection. The minimum dosage and regimen found to be effective are respectively substantially higher than the U.S. recommended daily allowance and more frequent than administration rates previously used in clinical trials. Also claimed are kits that permit individuals to monitor for elevated urinary excretion of useful substances which are water soluble, excreted in urine, and non-toxic at physiologically beneficial levels, such that optimal dosages and regimens can be determined.

REFERENCES:
patent: 4160696 (1979-07-01), Wu
patent: 5070085 (1991-12-01), Markham
Merck Manual of Diagnosis and Therapy; Berkow, R. ed., Merck & Co., Inc., Rahway N.J., 1977, pp. 1168, 2075, 1119.
Pelletier, J. Lab. & Clin. Med., vol. 72(4), Oct., 1968, pp. 674-679.
Hughes, R. E; Analyst, vol. 89, pp. 618-620, 1963.
Davies, M. B. et al., "Vitamin C: Its Chemistry and . . . ," Ryl Soc. of Chem. pp. 7-25, 1991.
Stare, F. J. and I. M. Stare, "Charles Glen King, 1896-1988," J. Nutr., 118:1272-7, 1988.
Roig, M. G. et al., "L-Ascorbic Acid: an Overview," Int. J. Food Sci., 44:59-72, 1993.
Block, G., "Vitamin C, Cancer and Aging," Age, vol. 16, pp. 55-58, 1993.
Marwick, C., "Cancer Institute Takes a Look at Ascorbic Acid," JAMA, 264:1926, 1990.
Wittes, R. E., "Vitamin C and Cancer," New Eng. J. Med., 312:178-9, 1985.
Burr, M. L. et al., "Vitamin C and Cholesterol . . ," Human Nutr., 39c:387-8, 1985.
Kimura, H. et al., "Dietary Ascorbic Acid Depresses . . . ," J. Nutr., 122:1904-9, 1992.
Uchida, K. et al., "Effect of Vitamin C Depletion . . . ," Nutr., 120:1140-7, 1990.
Blanchard, J. et al., "Comparison of Plasma . . . ," Eur. J. Clin. Nutr., 43:97-106, 1989.
Chavance, M. et al., "Vitamin Status . . . ," Eur. J. Clin. Nutr., 43:827-35, 1989.
Vallance, S., "Platelelts, Leukocytes and Buffy Layers . . . ," Hum. Nutr., 40c:35-41, 1986.
Vojdani, A. et al., "In Vivo Effect of Ascorbic . . . ," Nutr. Res., 13:753-764, 1993.
Pryor, W. A., "The Formation of Free Rad. . . ," Photochem. Photobiol., 28:787-801, 1978.
Harman, D., "The Aging Process," Proc. Natl. Acad. Sci. USA, 78:7128, 1981.
Tappel, A. L., "Vitamin E as the Biological . . . ," Vitam. Horm., 20:493-510, 1962.
Niki E. et al., "Inhibition of Oxidation . . . ," J. Biol. Chem., 259:4177-4182, 1984.
Harman, D., "Free Raidcal Theory . . . ," Lipofuscin-1987: State of the Art, pp. 3-21, 1988.
Olson, J. A. and R. E. Hodges, "The Scientific Basis . . . ," Nutr. Today, 20:14-15, 1985.
Blanchard, J. et al., "Effects of Age . . . ," Eur. J. Clin. Nutr., 44:447-460, 1990.
Omaye, T. S. et al., "Selected Methods . . . ," Methods in Enzymology, 62:3-11, 1979.

Affiliated with

Also associated with

Rating

Method for maintaining a continuously-saturated level of ascorbi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for maintaining a continuously-saturated level of ascorbi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for maintaining a continuously-saturated level of ascorbi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1927156